GLS4/RTV and TAF Drug-drug Interaction

Clinical trial NCT04551261 · COMPLETED

Trial details

NCT number: NCT04551261
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2021-01-10
Primary completion: 2021-03-12
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.